LAUSR

The severe acute respiratory syndrome – coronavirus 2 (SARS‐CoV‐2), the infectious agent responsible for COVID‐19 – has caused more than 2.5 million deaths worldwide and triggered a global pandemic. Even with successful vaccines being delivered, there is an urgent need for novel treatments to combat SARS‐CoV‐2, and other emerging viral diseases. While several organic small molecule drug candidates are in development, some effort has also been devoted towards the application of metal complexes as potential antiviral agents against SARS‐CoV‐2. Herein, the metal complexes that have been reported to show antiviral activity against SARS‐CoV‐2 or one of its target proteins are described and their proposed mechanisms of action are discussed.